Krystal Biotech, Inc. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2b6b908a-d161-4dd2-8244-a7ab4ff81dc1/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $204.8M | 2025-01-01 – 2025-12-31 | evidence 0001711279-26-000016 |
| FY 2024 | $89.2M | 2024-01-01 – 2024-12-31 | evidence 0001711279-25-000008 |
| FY 2023 | $10.9M | 2023-01-01 – 2023-12-31 | evidence 0001711279-24-000005 |
| FY 2022 | $-140.0M | 2022-01-01 – 2022-12-31 | evidence 0001711279-23-000008 |
| FY 2021 | $-69.6M | 2021-01-01 – 2021-12-31 | evidence 0001711279-22-000004 |
| FY 2020 | $-32.2M | 2020-01-01 – 2020-12-31 | evidence 0001711279-21-000006 |
| FY 2019 | $-19.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009550 |
| FY 2018 | $-10.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-009550 |
| FY 2017 | $-7.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005252 |
| FY 2016 | $-1.1M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-005252 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Krystal Biotech, Inc. — all facts · Revenue · Operating Income